Table 1.
Summary of actively recruiting clinical trials with CD19-targeted CARs
MDACC indicates MD Anderson Cancer Center; NIH, National Institutes of Health; FHCRC, Fred Hutchinson Cancer Research Center; NHL, non-Hodgkin lymphoma; and scFv, single-chain–variable fragment.
*Donor-derived EBV-CTLs.
†Donor-derived Tri-virus CTLs.
‡Donor-derived CD8+ central memory viral specific (EBV or CMV) T cells.
